User profiles for Gerardo Botti
Gerardo BottiDirettore Dipartimento Anatomia Patologica, Istituto Nazionale Tumori Napoli Verified email at istitutotumori.na.it Cited by 27490 |
[HTML][HTML] Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences
This review summarizes the main pathophysiological basis of the relationship between
metabolic syndrome, endocrine disruptor exposure and prostate cancer that is the most common …
metabolic syndrome, endocrine disruptor exposure and prostate cancer that is the most common …
Human Urokinase Receptor Concentration in Malignant and Benign Breast Tumors by in Vitro Quantitative Autoradiography: Comparison with Urokinase Levels
We measured the tissue concentration of human urokinase receptor (uPAR) in 22 breast
carcinomas and 9 benign breast lesions using in vitro quantitative autoradiography. Tissue …
carcinomas and 9 benign breast lesions using in vitro quantitative autoradiography. Tissue …
Towards the introduction of the 'Immunoscore'in the classification of malignant tumours
…, R Palmqvist, GV Masucci, G Botti… - The Journal of …, 2014 - Wiley Online Library
The American Joint Committee on Cancer/Union Internationale Contre le Cancer ( AJCC /
UICC ) TNM staging system provides the most reliable guidelines for the routine …
UICC ) TNM staging system provides the most reliable guidelines for the routine …
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
…, P Dundr, H Skalova, K Nemejcova, G Botti… - The Lancet, 2018 - thelancet.com
Background The estimation of risk of recurrence for patients with colon carcinoma must be
improved. A robust immune score quantification is needed to introduce immune parameters …
improved. A robust immune score quantification is needed to introduce immune parameters …
[HTML][HTML] Cancer classification using the Immunoscore: a worldwide task force
Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma
The prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression
remains inconclusive. We investigated the prevalence and distribution of mutations in these …
remains inconclusive. We investigated the prevalence and distribution of mutations in these …
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
Purpose: CXCR4 receptor and its unique ligand, the CXCL12 chemokine, have been recently
implicated in cancer metastasis. Evidence about the role of CXCR4/CXCL12 axis has …
implicated in cancer metastasis. Evidence about the role of CXCR4/CXCL12 axis has …
[HTML][HTML] The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with …
Background Empagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter
2, reduced the risk of hospitalization for heart failure and cardiovascular death in type 2 …
2, reduced the risk of hospitalization for heart failure and cardiovascular death in type 2 …
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study
…, G Troncone, L Palombini, G Chiappetta, G Botti… - The lancet …, 2008 - thelancet.com
Background In the USA, about 30 200 well-differentiated thyroid carcinomas were diagnosed
in 2007, but the prevalence of thyroid nodules is much higher (about 5% of the adult …
in 2007, but the prevalence of thyroid nodules is much higher (about 5% of the adult …
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced …
…, F Sandomenico, A Petrillo, G Botti… - Cancer immunology …, 2014 - Springer
Background Ipilimumab can induce durable disease control and long-term survival in patients
with metastatic melanoma. Identification of a biomarker that correlates with clinical benefit …
with metastatic melanoma. Identification of a biomarker that correlates with clinical benefit …